Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Current Assets (2020 - 2026)

GeneDx Holdings has reported Current Assets over the past 7 years, most recently at $270.6 million for Q1 2026.

  • Quarterly Current Assets rose 19.84% to $270.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $270.6 million through Mar 2026, up 19.84% year-over-year, with the annual reading at $268.3 million for FY2025, 35.52% up from the prior year.
  • Current Assets was $270.6 million for Q1 2026 at GeneDx Holdings, up from $268.3 million in the prior quarter.
  • Over five years, Current Assets peaked at $410.4 million in Q1 2022 and troughed at $162.2 million in Q2 2024.
  • The 5-year median for Current Assets is $213.3 million (2023), against an average of $240.5 million.
  • The largest YoY upside for Current Assets was 306.72% in 2022 against a maximum downside of 56.03% in 2022.
  • A 5-year view of Current Assets shows it stood at $212.6 million in 2022, then decreased by 14.24% to $182.3 million in 2023, then increased by 8.57% to $198.0 million in 2024, then soared by 35.52% to $268.3 million in 2025, then grew by 0.87% to $270.6 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Current Assets are $270.6 million (Q1 2026), $268.3 million (Q4 2025), and $237.6 million (Q3 2025).